Data Confirms Substantial Crop Yield Increases With Biologicals
March 13, 2024 Newly released third-party data from the 2023 growing season highlights unprecedented yield increases in the row and specialty crops of U.S. farmers who used novel biologicals developed by Locus Agriculture (Locus AG).
Outcomes were consistent across diverse agricultural conditions regardless of region, climate, or soil type. The results have spurred increased adoption and integration of the biologicals in seed treatment processes, retail offerings, and direct on-farm applications.
The performance of Locus AG’s biologicals was analyzed by contract research organizations and universities across 11 specialty crops and 12 row crops, including three “crossover” crops — one of the most extensive data sets in the industry. The products delivered significant yield increases — 4.2% to 26% in row crops and 5.2% to 37% in specialty crops — across various agricultural settings. Eight crop categories had statistically significant data, with a 95% or higher confidence rate in the reliability of the results. The crops were alfalfa, canola, corn, cotton, potato rice, soybean, and wheat.
Farmers leveraging Locus AG’s biologicals experienced significant returns on investment regardless of crop and location, from West Coast almonds to Midwest wheat to Southeast watermelon. It validates the biological’s adaptability and crucial role in enhancing crop productivity and profitability across the country.
“In a time when the agricultural sector is navigating challenges such as climate variability, rising input prices, and the need for sustainable practices, Locus AG’s U.S-made biological solutions are more vital than ever,” Kade Haas, Locus AG Senior Vice President, says. “Farmers can’t leave anything to chance. This data confirms that no matter what crop they grow or where they grow it, these premium biologicals are going to take their farming to the next level and ensure they have a successful growing season.”
There is a growing interest in using biologicals in U.S. agriculture. Farmers see domestic biologicals as a solution to help combat rising input prices, which 80% of them ranked as their No. 1 risk to profitability. However, experts note that the industry must be highly selective, focusing on products that offer consistent performance and quality strains backed by data.